313 related articles for article (PubMed ID: 19138237)
1. Withdrawal of inhaled steroids in children with non-cystic fibrosis bronchiectasis.
Guran T; Ersu R; Karadag B; Karakoc F; Demirel GY; Hekim N; Dagli E
J Clin Pharm Ther; 2008 Dec; 33(6):603-11. PubMed ID: 19138237
[TBL] [Abstract][Full Text] [Related]
2. Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis.
Guran T; Ersu R; Karadag B; Akpinar IN; Demirel GY; Hekim N; Dagli E
Pediatr Pulmonol; 2007 Apr; 42(4):362-9. PubMed ID: 17351928
[TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A
Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060
[TBL] [Abstract][Full Text] [Related]
4. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
[TBL] [Abstract][Full Text] [Related]
5. Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children.
Wyatt HA; Sampson AP; Balfour-Lynn IM; Price JF
Respir Med; 2000 Feb; 94(2):106-11. PubMed ID: 10714414
[TBL] [Abstract][Full Text] [Related]
6. Induced sputum in cystic fibrosis: within-week reproducibility of inflammatory markers.
Smountas AA; Lands LC; Mohammed SR; Grey V
Clin Biochem; 2004 Nov; 37(11):1031-6. PubMed ID: 15498533
[TBL] [Abstract][Full Text] [Related]
7. Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.
Yalçin E; Kiper N; Ozçelik U; Doğru D; Firat P; Sahin A; Ariyürek M; Mocan G; Gürcan N; Göçmen A
J Clin Pharm Ther; 2006 Feb; 31(1):49-55. PubMed ID: 16476120
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections.
Bodini A; D'Orazio C; Peroni D; Corradi M; Folesani G; Baraldi E; Assael BM; Boner A; Piacentini GL
Pediatr Pulmonol; 2005 Dec; 40(6):494-9. PubMed ID: 16229003
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of the range of neutrophil stimulating mediators in cystic fibrosis sputum.
Mackerness KJ; Jenkins GR; Bush A; Jose PJ
Thorax; 2008 Jul; 63(7):614-20. PubMed ID: 18245144
[TBL] [Abstract][Full Text] [Related]
10. Inhaled steroids improve quality of life in patients with steady-state bronchiectasis.
Martínez-García MA; Perpiñá-Tordera M; Román-Sánchez P; Soler-Cataluña JJ
Respir Med; 2006 Sep; 100(9):1623-32. PubMed ID: 16434174
[TBL] [Abstract][Full Text] [Related]
11. Markers of airway inflammation in primary ciliary dyskinesia studied using exhaled breath condensate.
Zihlif N; Paraskakis E; Tripoli C; Lex C; Bush A
Pediatr Pulmonol; 2006 Jun; 41(6):509-14. PubMed ID: 16617444
[TBL] [Abstract][Full Text] [Related]
12. Effects of a short-term rehabilitation program on airway inflammation in children with cystic fibrosis.
Moeller A; Stämpfli SF; Rueckert B; Rechsteiner T; Hamacher J; Wildhaber JH
Pediatr Pulmonol; 2010 Jun; 45(6):541-51. PubMed ID: 20503278
[TBL] [Abstract][Full Text] [Related]
13. Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis.
Cunningham S; McColm JR; Mallinson A; Boyd I; Marshall TG
Pediatr Pulmonol; 2003 Jul; 36(1):43-8. PubMed ID: 12772222
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
[TBL] [Abstract][Full Text] [Related]
15. Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosis.
Husson MO; Wizla-Derambure N; Turck D; Gosset P; Wallaert B
J Antimicrob Chemother; 2005 Jul; 56(1):247-9. PubMed ID: 15932936
[TBL] [Abstract][Full Text] [Related]
16. Correlation between cough frequency and airway inflammation in children with primary ciliary dyskinesia.
Zihlif N; Paraskakis E; Lex C; Van de Pohl LA; Bush A
Pediatr Pulmonol; 2005 Jun; 39(6):551-7. PubMed ID: 15806596
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO.
Porsbjerg C; Lund TK; Pedersen L; Backer V
J Asthma; 2009 Aug; 46(6):606-12. PubMed ID: 19657904
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil cell death, activation and bacterial infection in cystic fibrosis.
Watt AP; Courtney J; Moore J; Ennis M; Elborn JS
Thorax; 2005 Aug; 60(8):659-64. PubMed ID: 16061707
[TBL] [Abstract][Full Text] [Related]
19. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
[TBL] [Abstract][Full Text] [Related]
20. Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation.
Dal Negro R; Micheletto C; Tognella S; Visconti M; Turati C
Adv Ther; 2008 Oct; 25(10):1019-30. PubMed ID: 18821068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
